Steen Ingeberg

410 total citations
24 papers, 285 citations indexed

About

Steen Ingeberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Steen Ingeberg has authored 24 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Steen Ingeberg's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Steen Ingeberg is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Steen Ingeberg collaborates with scholars based in Denmark, United States and Switzerland. Steen Ingeberg's co-authors include Kaj Anker Jørgensen, Kirsten D. Bentsen, Timothy C. Kennedy, Fred R. Hirsch, John Kittelson, Wilbur A. Franklin, York E. Miller, Jørgen Jespersen, Robert L. Keith and Daniel T. Merrick and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Steen Ingeberg

24 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steen Ingeberg Denmark 10 91 71 56 49 48 24 285
Peter S. Kennedy United States 11 135 1.5× 140 2.0× 50 0.9× 91 1.9× 47 1.0× 26 391
Harris Naina United States 11 122 1.3× 60 0.8× 58 1.0× 116 2.4× 58 1.2× 60 356
Y Kadotani Japan 10 47 0.5× 114 1.6× 27 0.5× 103 2.1× 30 0.6× 35 345
Kotaro Kitani Japan 12 113 1.2× 128 1.8× 50 0.9× 163 3.3× 53 1.1× 45 366
Güngör Utkan Türkiye 9 121 1.3× 85 1.2× 32 0.6× 58 1.2× 47 1.0× 57 308
Alberto Agazzi Italy 9 112 1.2× 70 1.0× 56 1.0× 50 1.0× 129 2.7× 19 396
Karan Seegobin United States 10 81 0.9× 107 1.5× 36 0.6× 31 0.6× 57 1.2× 56 281
B Husberg Sweden 11 69 0.8× 68 1.0× 21 0.4× 203 4.1× 19 0.4× 34 435
Bernard Nalet France 11 172 1.9× 204 2.9× 85 1.5× 224 4.6× 32 0.7× 22 511
Ebru Çakır Türkiye 11 112 1.2× 134 1.9× 38 0.7× 132 2.7× 41 0.9× 47 411

Countries citing papers authored by Steen Ingeberg

Since Specialization
Citations

This map shows the geographic impact of Steen Ingeberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steen Ingeberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steen Ingeberg more than expected).

Fields of papers citing papers by Steen Ingeberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steen Ingeberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steen Ingeberg. The network helps show where Steen Ingeberg may publish in the future.

Co-authorship network of co-authors of Steen Ingeberg

This figure shows the co-authorship network connecting the top 25 collaborators of Steen Ingeberg. A scholar is included among the top collaborators of Steen Ingeberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steen Ingeberg. Steen Ingeberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jørgensen, Maja, et al.. (2015). Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer. Clinical Case Reports. 3(12). 987–989. 17 indexed citations
2.
Gang, Anne Ortved, Camilla Strøm, Mette Ølgod Pedersen, et al.. (2011). R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology. 23(1). 147–153. 52 indexed citations
3.
Brown, Peter de Nully, Lars Møller Pedersen, Bjarne Bach Pedersen, et al.. (2008). Follicular lymphoma in young patients (>50 yrs): A population-based analysis of the Danish lymphoma registry. Annals of Oncology. 19. 176–176. 4 indexed citations
4.
Merrick, Daniel T., John Kittelson, Steen Ingeberg, et al.. (2006). Analysis of c-ErbB1/Epidermal Growth Factor Receptor and c-ErbB2/HER-2 Expression in Bronchial Dysplasia: Evaluation of Potential Targets for Chemoprevention of Lung Cancer. Clinical Cancer Research. 12(7). 2281–2288. 57 indexed citations
5.
Merrick, Dan, John Kittelson, Sun Young Rha, et al.. (2006). Analysis of c-erb-1 (EGFR) and c-erb-2 (HER2) expression in bronchial dysplasia: Evaluation of potential targets for chemoprevention of lung cancer. Journal of Clinical Oncology. 24(18_suppl). 7070–7070. 1 indexed citations
6.
7.
8.
Hansen, Mads, Peter Gimsing, Steen Ingeberg, H Jans, & Ebba Nexø. (1992). Cobalamin binding proteins in patients with HIV infection. European Journal Of Haematology. 48(4). 228–231. 7 indexed citations
9.
Pedersen, Court, et al.. (1989). Serum thymidine kinase — a marker of bone marrow toxicity during treatment with zidovudine. AIDS. 3(11). 743–746. 9 indexed citations
10.
Gram, Jørgen, Jørgen Jespersen, Steen Ingeberg, Kirsten D. Bentsen, & E Bach. (1985). Plasma Histidine-rich glycoprotein and plasminogen in patients with liver disease. Thrombosis Research. 39(4). 411–417. 12 indexed citations
11.
Jørgensen, Bo, et al.. (1984). Decreased Blood Platelet Volume and Count in Patients with Liver Disease. Scandinavian Journal of Gastroenterology. 19(4). 492–496. 24 indexed citations
12.
Jespersen, Jørgen, Steen Ingeberg, & Elsa Bach. (1983). Antithrombin III and Platelets during the Normal Menstrual Cycle and in Women Receiving Oral Contraceptives Low in Oestrogen. Gynecologic and Obstetric Investigation. 15(3). 153–162. 8 indexed citations
13.
Ingeberg, Steen, et al.. (1983). [Thrombocytosis. A review of 500 cases].. PubMed. 145(40). 3071–2. 1 indexed citations
14.
Ingeberg, Steen, et al.. (1983). Prediction of Spleen Size by Routine Radioisotope Scintigraphy. Acta Haematologica. 69(4). 243–248. 9 indexed citations
15.
Ingeberg, Steen, et al.. (1982). Bone Mineral Content in Myelomatosis. Acta Medica Scandinavica. 211(1-2). 19–21. 6 indexed citations
16.
Christensen, Mogens, Steen Ingeberg, Jens Brøchner‐Mortensen, & P. Rødbro. (1982). Variable Interpretation of Liver Scintigraphy in Malignancy as an Aid in Clinical Decision‐Making. Acta Medica Scandinavica. 211(1-2). 23–26. 3 indexed citations
17.
Jespersen, Jørgen & Steen Ingeberg. (1981). The thrombogenic effect of haemodialysis assessed by its influence on clot retraction, platelet volume, and platelet number. Clinical Hemorheology and Microcirculation. 1(3). 235–239. 1 indexed citations
18.
Ingeberg, Steen, et al.. (1981). Whole body bone scintigraphy compared to conventional radiography in detecting bone lesions in multiple myeloma.. PubMed. 28(5). 207–9. 3 indexed citations
19.
Jørgensen, Kaj Anker, et al.. (1980). Alterations in Plasma Antithrombin III Following Total Hip Replacement and Elective Cholecystectomy. Scandinavian Journal of Haematology. 24(2). 101–104. 9 indexed citations
20.
Jørgensen, Kaj Anker & Steen Ingeberg. (1979). Platelets and Platelet Function in Patients with Chronic Uremia on Maintenance Hemodialysis. ˜The œNephron journals/Nephron journals. 23(5). 233–236. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter S. Kennedy Breakdown of academic impact, for papers by Harris Naina Breakdown of academic impact, for papers by Y Kadotani Breakdown of academic impact, for papers by Kotaro Kitani Breakdown of academic impact, for papers by Güngör Utkan Breakdown of academic impact, for papers by Alberto Agazzi Breakdown of academic impact, for papers by Karan Seegobin Breakdown of academic impact, for papers by B Husberg Breakdown of academic impact, for papers by Bernard Nalet Breakdown of academic impact, for papers by Ebru Çakır
Rankless by CCL
2026